Veeva Systems (NYSE:VEEV) today introduced its first application specifically built for clinical research centers, Veeva Vault SiteDocs. The new solution will help sites more effectively manage regulatory documentation and trial information to speed clinical research. Now clinical research centers can reduce the administrative burden of executing studies by streamlining document and trial processes for site qualification, study activation, and investigator site file management.
Were pleased to partner with Veeva and have the opportunity to leverage an innovative solution thats designed for how sites work, said Dr. Jeff Kingsley, founder and CEO, IACT Health. Veeva Vault SiteDocs gives greater visibility into regulatory document status and makes it easier for the clinical research community to conduct high-quality, compliant clinical trials.
Veeva Vault SiteDocs provides sites a single application for managing trial documents and processes to speed study activation. With continuous visibility into document quality, completeness, and accuracy, Vault SiteDocs gives clinical research centers a full view into study progress for improved compliance and inspection-readiness.
Were honored to support the important work of clinical research centers and partner with organizations such as IACT Health and Penn Medicine, said Jennifer Goldsmith, senior vice president of Veeva Vault. Veeva Vault SiteDocs aims to simplify study execution so research staff can focus on the science and accelerate their research efforts.
Veeva Vault SiteDocs is available today for clinical research centers. Join Veeva at the upcoming 2018 Global Site Solutions Summit, Oct. 12-14, to learn more and see a demonstration of Veeva Vault SiteDocs in booth #501.
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
For more information, visit: veeva.com/VaultSiteDocs Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veevasystems on Twitter: twitter.com/veevasystems Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 650 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.
This release contains forward-looking statements, including the market demand for and acceptance of Veevas products and services, the results from use of Veevas products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veevas historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veevas expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veevas financial results are included under the captions, Risk Factors and Managements Discussion and Analysis of Financial Condition and Results of Operations, in the companys filing on Form 10-Q for the period ended July 31, 2018. This is available on the companys website at veeva.com under the Investors section and on the SECs website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.